Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CUSP9v3 for Recurrent Glioblastoma
NCT02770378Phase 2Completed
- Sponsor
- Ulm University
- Start
- Nov 2016
- Primary completion
- Oct 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide, aprepitant, minocycline, disulfiram, celecoxib in glioblastoma (GBM), sponsored by Ulm University. Started Nov 2016; status: completed.
02
Drugs
temozolomideaprepitantminocyclinedisulfiramcelecoxib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT02770378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02770378.